NPI: 1689979775 · BATESVILLE, AR 72501 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 01/20/2011
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 01/20/2011 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 9,414 | $86K |
| 2019 | 11,666 | $103K |
| 2020 | 11,675 | $60K |
| 2021 | 11,257 | $86K |
| 2022 | 7,015 | $150K |
| 2023 | 1,701 | $18K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 16,079 | 1,348 | $147K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 21,016 | 1,040 | $102K |
| 82728 | 400 | 381 | $56K | |
| 83970 | 498 | 465 | $46K | |
| 83550 | 428 | 410 | $30K | |
| A4657 | Syringe, with or without needle, each | 1,235 | 1,109 | $30K |
| 83540 | 429 | 411 | $25K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 7,828 | 615 | $17K |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 538 | 370 | $16K |
| 82108 | 72 | 71 | $15K | |
| 85041 | 813 | 781 | $9K | |
| 85048 | 813 | 781 | $7K | |
| J1756 | Injection, iron sucrose, 1 mg | 2,358 | 599 | $2K |
| 85045 | 203 | 200 | $183.42 | |
| G0008 | Administration of influenza virus vaccine | 18 | 16 | $53.18 |